Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Stocks in this Quantisnow insightHealth Care
Historical context for OM
Across the 10 sessions after earlier OM headlines, the stock closed higher 6 times and lower 4 times, with a median move of 4.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | OM | SPY |
|---|---|---|---|
| May 12, 2026 | Outset Medical to Present at RBC Global Healthcare Conference | +5.2% | -0.2% |
| Apr 28, 2026 | Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 | -2.0% | -0.5% |
| Apr 9, 2026 | Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | +2.9% | +0.6% |
| Apr 7, 2026 | Outset Medical Names Derick Elliott as Executive Vice President of Commercial | +0.5% | +0.0% |
| Jan 27, 2026 | Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Plannedand 1 other headline that session | +14.3% | +0.4% |
| Jan 12, 2026 | Outset Medical Reports Unaudited Fourth Quarter and 2025 Results | +22.1% | +0.2% |
Quantisnow market dataNASDAQ
OM
Outset Medical Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2020
Get push alerts for OM
Full OM profile on Quantisnow Follow OM and get a push notification the moment its next story breaks.